Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study

Stopped See termination reason in detailed description.

Conditions

• Fibromyalgia
• Painful Diabetic Peripheral Neuropathy

Interventions

• OTHER: prior authorization
• OTHER: no prior authorization
• OTHER: prior authorization
• OTHER: no prior authorization

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.